Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 25,000 shares at $27.63 ($691K) on 2025-01-28, disclosed to the SEC on 2025-01-30.
Scheduled sale ($691k) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2026-04-02 | $926K | — | Filing → |
| EWTX | SELL | 2026-03-31 | $1.4M | — | Filing → |
| EWTX | SELL | 2026-03-30 | $1.0M | — | Filing → |